Orthopedic Cell Therapy Market Size, Share, and Trend Analysis | Global | 2025-2031 | MedCore | Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market

The global orthopedic cell therapy market was valued at $551.3 million in 2024 and is projected to grow at a CAGR of 7.2%, reaching $895.8 million by 2031.

This market includes two primary therapy types:

• Platelet-Rich Cell Therapy
• Bone Marrow Cell Therapy
• Market Insights & Data Coverage
• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

• The COVID-19 pandemic caused a temporary decline in sales due to the postponement of elective procedures.
• By 2022, the market rebounded, returning to a trajectory of steady growth.
• Advancements in Cell Therapy Technology:
• Growth in regenerative medicine is driving demand for platelet-rich plasma (PRP) and bone marrow aspirate (BMA) therapies.
• Improved processing systems are enhancing the efficacy and adoption of orthopedic cell therapies.
• Increased Adoption in Orthopedics & Sports Medicine:
• Rising demand for minimally invasive treatments is fueling the market.
• Soft tissue injuries, joint reconstructions, and spine treatments are key growth areas.

Market Share Insights

Top Competitors in the Global Orthopedic Cell Therapy Market (2024):

1 Terumo

• Market leader with its Harvest Technologies division.
• Offers Harvest® BMAC, Harvest® PRP, and the Harvest® AdiPrep® adipose tissue concentrator.
• The Harvest® SmartPrep system enables multicellular processing for bone marrow, blood, and adipose tissue.

2 Zimmer Biomet

• Second-largest market share with its Plasmax® Plasma concentration system and BioCUE™ System.
• BioCUE™ System processes both bone marrow and whole blood for cell therapy applications.

3 Arthrex

• Third-largest competitor, known for its Angel® cPRP and Bone Marrow Processing System.
• The Angel® System automates the separation and concentration of PRP and BMA for orthopedic and soft tissue applications.

Market Segmentation Summary

• Platelet-Rich Cell Therapy Market
• Indications: Soft Tissue, Spine, Cardiac, Orthopedic, Plastics.
• Bone Marrow Cell Therapy Market
• Indications: Soft Tissue, Spine, Trauma, Joint Reconstructions.

Global Research Scope

• Regions Covered:
• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
• Western Europe (Germany, France, U.K., Spain, Italy)
• Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
• Middle East (Saudi Arabia, UAE, Israel)
• Asia Pacific (China, Japan, India, South Korea, Australia)
• Africa (South Africa, Egypt, Nigeria, Kenya)
• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• Internal Database